3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
15
Breast Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Glioblastoma
7
Esophageal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Burkitt Lymphoma
7
Uterine Cervical Neoplasms
6
Rhabdomyosarcoma
6
Squamous Cell Carcinoma of Head and Neck
4
Esophageal Squamous Cell Carcinoma
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Rhabdomyosarcoma, Embryonal
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Medulloblastoma
3
Lymphoma, Follicular
3
Lung Neoplasms
3
Hodgkin Disease
3
Head and Neck Neoplasms
3
Gliosarcoma
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Vaginal Neoplasms
2
Rhabdomyosarcoma, Alveolar
2
Prostate Adenocarcinoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Interventions
Cyclophosphamide
3
Epirubicin
2
Docetaxel
2
Carboplatin
2
Capecitabine
2
Azacitidine
2
venetoclax
1
tegafur-gimeracil-oteracil
1
taxane
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pirarubicin
1
pertuzumab
1
pembrolizumab
1
olaparib
1
cc-486
1
Trastuzumab
1
Thalidomide
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Nivolumab
1
Monatide (IMS 3015)
1
Methotrexate
1
Magnetic Resonance Imaging
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pathologic Complete Response
×
Radiation
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled